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Abstract
Background and purpose: TRPV1 is expressed in sensory neurons and vascular smooth muscle cells, contributing to both
pain perception and tissue blood distribution. Local desensitization of TRPV1 in sensory neurons by prolonged, high dose
stimulation is re-engaged in clinical practice to achieve analgesia, but the effects of such treatments on the vascular TRPV1
are not known.
Experimental approach: Newborn rats were injected with capsaicin for five days. Sensory activation was measured by eye
wiping tests and plasma extravasation. Isolated, pressurized skeletal muscle arterioles were used to characterize TRPV1
mediated vascular responses, while expression of TRPV1 was detected by immunohistochemistry.
Key results: Capsaicin evoked sensory responses, such as eye wiping (3.662.5 versus 15.561.4 wipes, p,0.01) or plasma
extravasation (evans blue accumulation 1063 versus 3367 mg/g, p,0.05) were reduced in desensitized rats. In accordance,
the number of TRPV1 positive sensory neurons in the dorsal root ganglia was also decreased. However, TRPV1 expression in
smooth muscle cells was not affected by the treatment. There were no differences in the diameter (192627 versus
19468 mm), endothelium mediated dilations (evoked by acetylcholine), norepinephrine mediated constrictions, myogenic
response and in the capsaicin evoked constrictions of arterioles isolated from skeletal muscle.
Conclusion and implications: Systemic capsaicin treatment of juvenile rats evokes anatomical and functional
disappearance of the TRPV1-expressing neuronal cells but does not affect the TRPV1-expressing cells of the arterioles,
implicating different effects of TRPV1 stimulation on the viability of these cell types.
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Introduction
The therapeutic potential of TRPV1 modulation in various
painful states has been recognized in a series of publications some
40 years ago [1–4]. In these early works capsaicin specific
responses were related to a specific receptor, which could be
desensitized by the application of high dose of capsaicin at an early
phase of the life of the rat. These robust changes in sensory
function led to the recognition of pharmacological approach to
manipulate nociceptors [5]. Capsaicin desensitization therefore
become a powerful approach to characterize peripheral nocicep-
tors and to achieve topical analgesia. Although molecular
identification of the receptor responsible for capsaicin mediated
responses [6] resulted in a rise in therapeutic interest in systemic
TRPV1 modulation to inhibit the pain pathway, no successful
antagonists were introduced to the market [7], probably due to the
unfavorable side effects of the systemic treatment [8]. On the other
hand, local capsaicin desensitization recently re-emerged as a
therapeutic method to selectively defunctionalize capsaicin
expressing sensory neurons and to achieve local analgesia [9,10].
TRPV1 regulates cellular Ca2+ levels via direct permeation
(PCa/PNa,10) [6], which concomitantly down-regulates its own
activity. Among the Ca2+-activated enzymes that are believed to
play pivotal roles in this TRPV1 acute desensitization process is
the Ca2+/calmodulin-dependent Ser/Thr phosphatase 2B, calci-
neurin [11–13], which dephosphorylates TRPV1 receptors.
Conversely, phosphorylations at several consensus sites for protein
kinase C (PKC) [14–16] and cAMP-dependent protein kinase A
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(PKA) [17,18] can reduce the Ca2+- mediated desensitization of
TRPV1. Thus, the dynamic balance between the Ca2+-dependent
phosphorylation and dephosphorylation of the TRPV1 protein
appears to play a critical role in the acute desensitization of
TRPV1 [12].
In contrast with the acute desensitization, neonatal capsaicin
treatment results in the deletion of TRPV1 expressing peripheral
sensory neurons [19,20]. Capsaicin evoked sensory neuronal cell
death may be mediated by Ca2+ overload of the TRPV1
expressing cells [21].
Activation of TRPV1 leads to central (pain) and to local
‘‘sensory-efferent’’ effects [22]. These include the release of
vasoactive agents (such as calcitonin gene-related peptide) from
sensory neurons and subsequent vasorelaxation [23]. In recent
years, TRPV1 expression has been identified in many cells types in
addition to sensory neurons as referenced by Keeble et al in recent
reviews [24,25]. In particular, TRPV1 expression was detected in
various cell types in the brain [26], and in arteriolar smooth
muscle [27]. In accordance with this latter non-neuronal
localization, activation of TRPV1 resulted in a substantial
vasoconstriction in vivo and in vitro [27,28] through direct activation
of endogenous TRPV1 in vascular smooth muscle cells [29].
The effects of capsaicin desensitization were investigated here.
Capsaicin desensitization is the only clinically available, approved
and effective treatment option to regulate TRPV1 mediated
sensory functions. Since functional TRPV1 expression has been
identified in non-neuronal cells, these receptors may have
physiological functions which may also be modulated by
therapeutic capsaicin applications. Morphological and functional
studies were performed to reveal differences between desensitiza-
tion of sensory neurons and vascular smooth muscle cells. Our
data suggest that capsaicin desensitization has only a transient
effect on the vascular TRPV1. Therefore, vascular TRPV1
function is maintained even if the same treatment depletes sensory
neurons.
Methods
Animals, anaesthesia and general preparation in the in
vivo experiments
Male Wistar Kyoto (WKY/NCrl) rats obtained from Charles
River (Isaszeg, Hungary) were fed by CRLT/N chow (Szinbad
Kft, Godollo, Hungary). Experiments were performed on male
Wistar rats weighing about 250 g at the beginning of the
experiments raised on a standard laboratory food and water ad
libitum. Anaesthesia was performed with 50 mg/kg i.p. thiopental.
Animal experiments were carried out and approved by the
Hungarian Ministry of Rural Development and by the University
of Debrecen, Medical and Health Science Center (Registration
number: 31/2007/DE MA´B), and were in accordance with the
standards established by the National Institutes of Health.
Capsaicin pretreatment of rats
Newborn rats (at day 14 of life) were pretreated with Diaphyllin
(Richter, Hungary), Bricanyl (Astra Zeneca, Hungary), and
atropine (Egis, Hungary, 100 g/0,1 ml i.p.). Ten minutes later
animals were injected with capsaicin (subcutaneously). The
procedure was repeated for a total of five consecutive days. The
total dose of capsaicin was 300 mg/kg, administered on a dose
schedule of 10 mg/kg, 20 mg/kg; 50 mg/kg; 100 mg/kg; and
120 mg/kg on days 1 through 5, respectively. Rats were then kept
in the animal facility for 10 weeks when experiments were
performed. The weight of the rats was in the range of 360–492 g
at this time.
Measurement of capsaicin evoked sensory irritation
One drop (10 ml) of capsaicin solution (50 mg/ml in physiolog-
ical saline) was put into the right or left conjunctiva of the rat, in a
random order. The number of eye wipes was counted during 60 s.
Rats were scarified after capsaicin treatments.
Measurement of capsaicin evoked involuntary sensory
neuronal functions
Plasma extravasation was measured according to Pinter et al.
[30]. Rats were anesthetised and a tail vein was cannulated for the
injection of Evans blue dye (30 mg/kg). One min after Evans blue
administration capsaicin was injected (1 mg/kg, i.v.). Rats was
sacrificed by transcardiac perfusion with 50 ml of 0.9% w/v saline,
at 37uC, through the left cardiac ventricle 10 min after injection of
Evans blue. The urinary bladder was removed and weighed, and
the Evans blue was extracted in 1 ml of formamide for 24 h. Evans
blue content was determined by spectrophotometry (at 620 nm).
Plasma extravasation was expressed as the content of Evans blue
dye in micrograms per gram of wet tissue.
Preparation of cannulated skeletal muscle arterioles
Isolation of the skeletal (gracilis) muscle arterioles of the rat and
diameter measurement of the arterioles were performed as
described earlier [12]. The internal diameters of the cannulated
skeletal muscle (m. gracilis) arterioles were determined at the
midpoint of the arteriolar segment by videomicroscopy. Cannu-
lated arterioles were incubated in a physiological solution (PSS,
composition in mM: 110 NaCl, 5.0 KCl, 2.5 CaCl2, 1.0 MgSO4,
1.0 KH2PO4, 5.0 glucose and 24.0 NaHCO3 equilibrated with a
gas mixture of 10% O2 and 5% CO2, 85% N2, at pH 7.4.).
Experiments were started after the development of a spontaneous
tone in response to intraluminal pressure of 80 mmHg. First,
acetylcholine (1 nM–10 mM) was used to determine dilatative
capacity (acetylcholine causes endothelium dependent vasodilata-
tion), and then norepinephrine (1 nM–10 mM) was applied to
measure maximal constrictive response (norepinephrine causes
smooth muscle dependent constriction). Vascular autoregulation
(myogenic response) were also determined. Intraluminal pressure
was increased from 20 to 120 mmHg in 20 mmHg increments
and arteriolar diameter was measured after 4 min incubations at
each intraluminal pressures. These measurements were performed
in PSS to assess the active myogenic response. Passive diameter
was determined in Ca2+ free PSS at the end of the experiments.
Changes in diameter in response to a TRPV1 agonist was tested
with cumulative dose (capsaicin, 1 nM–30 mM).
Immunohistochemical procedures
Tissue sections were prepared as detailed earlier [27]. In short,
rat skeletal muscle (m. gracilis), dorsal root ganglions (thoracic)
were dissected from Wistar rats and were embedded in Tissue-Tek
O.C.T compound (Electron Microscopy Sciences, Hatfield, PA,
USA). Cryostat sections (thickness 10 mm) were placed on adhesive
slides and fixed in acetone for 10 min. The slices were blocked
with normal goat sera (1.5% in PBS, Sigma, St. Louis, MO, USA)
for 20 min and stained with an anti-capsaicin receptor antibody
(PC 547 (rabbit), Calbiochem, San Diego, CA) at a 1:500 (for
gracilis muscle) and 1:200 dilution (for dorsal root ganglia), and co-
stained with smooth muscle actin antibody (NCL-SMA, dilution,
1:50; Novocastra Laboratories, New Castle, UK) or with a
neurofilament-specific antibody (dilution, 1:50; Sigma) in the
blocking buffer. Then, the slices were incubated with biotinylated
anti-rabbit (Jackson, Suffolk, England, 1:200) and FITC conju-
gated anti-mouse antibodies (Jackson, Suffolk, England, 1:100).
Desensitization of Vascular TRPV1
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Biotinylated antiobody was detected by Cy3 conjugated strepta-
vidine (Jackson, Suffolk, England, 1:500). The pictures were
captured by a Scion Corporation (Frederick, MA) digital camera
attached to a Nikon Eclipse 80i fluorescent microscope (Nikon,
Tokyo, Japan) further processed by ImageJ (freeware from www.
nih.gov) software.
Materials and solutions
Chemicals were from Sigma-Aldrich (St. Louis, MO, USA).
Capsaicin (8-Methyl-N-vanillyl-trans-6-nonenamide) was dissolved
in ethanol. Norepinephrine and acetylcholine were dissolved in
distilled water. Evans Blue concentration was measured by using a
NOVOstar plate reader.
Data analysis and statistical procedures
Arteriolar diameter was determined by measuring the distances
between the intraluminal sides of the arteriolar wall (inner
diameter). Data are shown as average diameter 6 S.E.M.
Statistical analysis was made by Microsoft Excel using Student’s
t-tests. P-values,0.05 were considered to be significant.
Results
Effects of desensitization on capsaicin-evoked eye-
wiping movements
Sensory irritation was assessed by eye wiping assays. Capsaicin
evoked a high number of wiping movements in control rats
(15.561.4 wiping movements, n = 10), while desensitized rats
(neonatal capsaicin application) were almost insensitive to the
same treatment (3.662.5 wipes, n = 10; p,0,001, Fig. 1A).
Effects of desensitization on capsaicin – induced plasma
extravasation
Systemic activation of TRPV1 expressing sensory neurons by
capsaicin resulted in an increase in Evans blue accumulation in the
urinary bladder of control rats (3367 mg/g wet tissue; n = 9,
Fig. 1B). Neonatal capsaicin desensitization significantly attenuat-
ed this response (Evans blue accumulation decreased to 1063 mg/
g wet tissue; n = 5, p = 0,03 versus control, Fig. 1B).
Immunochemistry of TRPV1
Dorsal root ganglia (DRG) were isolated from control and
desensitized rats and TRPV1 expression was evaluated by
immunohistochemistry. TRPV1 expression was found in a subset
of neurons (neurons were visualized by neurofilament specific
staining) in control rats but was missing in desensitized rats (Fig. 2).
However, TRPV1 like immunostaining was also found in blood
vessels associated with the DRGs, irrespective to the desensitiza-
tion procedure. The localization of that TRPV1 expression to
vascular smooth muscle cells was tested by the co-application of
antisera against TRPV1 and vascular smooth muscle actin (Fig. 3).
Indeed, some of the TRPV1 immunoreactivity overlapped with
vascular smooth muscle specific staining. We thus find that, that
while neonatal capsaicin treatment was found to be effective to
eliminate TRPV1 immunoreactivity in sensory neurons, it was
without effects on the vascular smooth muscle cell located TRPV1
immunoreactivity (Fig. 3). Similarly, TRPV1 expression was not
affected by neonatal capsaicin treatment in the gracilis muscle of
the rat (Fig. 4).
Physiological effects of neonatal capsaicin
desensitization on isolated skeletal muscle arterioles
There were no significant differences between control and
desensitized rats in acetylcholine mediated dilation (Fig. 5A),
norepinephrine mediated constriction (Fig. 5B) and vascular
Figure 1. Effects of neonatal capsaicin desensitization on sensory functions. Rats were treated with saline (Control) or with capsaicin
(Desensitized) at 14 days of life. Sensory functions were measured 10 weeks after capsaicin treatment. (A) Eye wiping (a measure of capsaicin evoked
sensory irritation) was reduced in desensitized rats (n = 10 in both groups, p,0.001). (B) Plasma extravasation was similarly reduced (Evans blue
accumulation, a measure of capsaicin mediated neurogenic inflammation) (n = 9 for Control and n= 5 for Desensitized, p = 0.03).
doi:10.1371/journal.pone.0078184.g001
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autoregulation (spontaneous myogenic response, Fig. 5C) in
isolated skeletal muscle resistance arteries. Moreover, capsaicin
mediated arteriolar constrictions were also unaffected in both
groups of rats (Fig. 5D), which was in contrast with the capsaicin
mediated sensory functions (Fig. 1).
Direct application of capsaicin (1 mmol/L) resulted in a
transient constriction (maximal decrease of arteriolar diameter
was 7063% at 105 s) followed by a dilation in the continuous
presence of capsaicin (constriction at the end of the 20 min long
incubation was only 866%) (Fig. 6A). Besides to the acute
desensitization (desensitization in the presence of the agonist)
tachyphylaxis (desensitization to the repeated application of the
agonist) was also determined. Although tachyphylaxis was
apparent upon the second capsaicin challenge (first versus second
treatment on Fig. 6A), capsaicin treatment did not eliminate
capsaicin responsiveness completely (maximal constriction upon
Figure 2. Effects of neonatal capsaicin desensitization on sensory TRPV1 expression. TRPV1 expression was examined in the dorsal root
ganglia of control and capsaicin desensitized (neonatal capsaicin treatment) adult rats. Tissue sections were probed with antibodies specific to TRPV1
(red) and neurofilament (green). TRPV1 expression was present in a subset of sensory neurons in control rats, which was missing in desensitized rats
within the dorsal root ganglia. However, TRPV1 immunoreactivity was also found in non-neuronal cell types, located at the outer regions of ganglia
(regions occupied by sensory neurons are indicated by the freehand drawing). Images are representative of at least 10 sections.
doi:10.1371/journal.pone.0078184.g002
Figure 3. TRPV1 immunoreactivity in vascular smooth muscle cells. Rat dorsal root ganglia sections were co-stained by anti TRPV1 (red) and
anti vascular smooth muscle actin (SMA, green) antibodies. Some of the TRPV1 positive cells were co-stained by the antibody specific to vascular
smooth muscle actin, suggesting TRPV1 expression in this cell type. Moreover, vascular TRPV1 expression was not affected by neonatal capsaicin
treatment (note similar TRPV1 staining in SMA positive regions of control and desensitized rats). Images are representative of at least 6 sections.
doi:10.1371/journal.pone.0078184.g003
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second capsaicin treatment was 2669% at 270 s, while constric-
tion was only 1064% at the end of the 20 min long treatment,
Fig. 6A). To test if capsaicin mediated desensitization may affect
the viability of the different vascular cell types, smooth muscle
(norepinephrine, Fig. 6B) and endothelium (acetylcholine, Fig. 6C)
mediated responses were also tested. Norepinephrine mediated
responses were almost identical (Fig. 6B), while the limited shift in
acetylcholine responses (Fig. 6C) did not reach the level of
significance (p.0.05), suggesting that acute in vitro TRPV1
desensitization did not have a significant effect of TRPV1
independent functions of skeletal muscle arterioles.
Discussion
Capsaicin containing herbs were used from the prehistoric era
in the medicinal efforts to relieve pain and inflammation [31].
Capsaicin treatment was introduced to eliminate sensory responses
about fifty years ago [3] and these experiments lead to the
identification of primary nociceptors [5]. Cloning of the receptor
(named as TRPV1) and the development of knock out models
confirmed its role in inflammatory hyperalgesia [32]. It was even
proposed that there are endogenous ligands (endovanilloids)
binding to the capsaicin binding site of TRPV1 [23], although
the physiological relevance of these proposed endovanilloids to
modulate TRPV1 are still under debate, especially in skeletal
muscle arterioles [33].
TRPV1 appeared to be a sensory neuronal specific receptor,
which has a role in nociception and can be selectively targeted by
small molecules. Not surprisingly, TRPV1 become a pharmaceu-
tical target to develop a new generation of painkillers as well as to
treat other therapeutic conditions [7]. Although almost all of the
major pharmaceutical companies initiated a TRPV1 research
program, these efforts have not yet produced approved drugs [34].
The apparent failure of introduction of TRPV1 antagonists into
the clinical practice is probably not the result of insufficient
potency of the developed antagonists [34]. Nonetheless, clinical
application of the TRPV1 agonists capsaicin and resiniferatoxin
offer an alternative to TRPV1 antagonists for treating challenging
painful conditions such as neuropathic pain [10,35]. It is
important to note that therapy to achieve desensitization is
different from that based on the application of antagonists in terms
of the potential side effects. Antagonists may cause side effects if
their receptors play a significant physiological role, while
desensitizing agonists may activate receptors which are expressed,
but without much physiological role. Interestingly, while recent
data suggested that TRPV1 may be expressed in other cell types
than sensory neurons (see Keeble et al [24,25] for references and
[36]), the potential side effects of capsaicin desensitization had not
been tested on these receptors.
Selective elimination of TRPV1 positive sensory neurons and
attenuation of capsaicin evoked sensory neuron mediated effects
were found following systemic neonatal capsaicin treatment
confirming earlier data [37,38]. Effects of this treatment on the
vascular smooth muscle located TRPV1 was addressed here for
the first time. It was found that neonatal capsaicin treatment does
not affect arteriolar TRPV1 function and expression. It is in
accordance with the limited if any permanent vascular effects of
neonatal capsaicin desensitization.
It has been suggested that capsaicin has biphasic effects on the
vasculature: at lower concentrations, capsaicin (up to 10 nM)
evokes vasodilation in skin due to sensory nerve activation, while
higher concentrations (0.1–1 mM) lead to substantial constrictions
in skeletal muscle arterioles due to non-neuronal TRPV1
stimulation [27]. This apparent difference in sensitivity may be
due to (i) receptor sensitivity or (ii) a difference in TRPV1 receptor
density in skin and skeletal muscle arterioles as been concluded by
Fernandes et al [25]. As the matter of the first hypothesis a recent
study designed to detect pharmacological differences between
TRPV1 populations in the sensory nerves and in the arteriolar
smooth muscle proved that these TRPV1 populations are
pharmacologically different: some TRPV1 agonists were irritative
(a measure of sensory neuronal TRPV1 activation), but without
Figure 4. Effects of neonatal capsaicin desensitization on vascular TRPV1 expression. Skeletal muscle (gracilis muscle of the rat) tissue
sections were stained with anti-TRPV1 (red) and anti-vascular smooth muscle actin (SMA, green) antibodies. There appeared a complete overlap of
the staining patterns (merged images). Arteriolar TRPV1 expression was not affected by neonatal capsaicin desensitization, similarly to the vascular
TRPV1 in the dorsal root ganglia. Images are representative of at least 10 sections.
doi:10.1371/journal.pone.0078184.g004
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vasoconstrictive effects [29]. Capsaicin evoked vasoconstriction
was mediated by direct activation of arteriolar smooth muscle
located TRPV1 and was missing in TRPV1 knock out mice,
suggesting that both the irritation (sensory neuronal response) and
vasoconstriction (smooth muscle response) are mediated by
TRPV1 [29]. As the matter of the second hypothesis (different
expression of TRPV1 in perivascular nerves) a clear tissue specific
difference was described. Arteries in the skin were densely
innervated by TRPV1 positive fibers, in contrast with arteries in
the skeletal muscle [27]. This fact suggests that sensory neuron
mediated dilation plays a dominant role in the skin upon TRPV1
stimulation, but may have a limited effect in the skeletal muscle.
TRPV1 was found to be important in inflammation affecting
arteriolar diameter. The most prominent contribution of TRPV1
stimulation to the neurogenic inflammation is the local release of
neuropeptides (such as CGRP and substance P) from the sensory
neurons [23], which is missing in capsaicin desensitized rats [5].
However, it was found recently, that TRPV1 stimulation also
increases the plasma concentration of PACAP-38, an anti-
inflammatory peptide [39], and somatostatin [40] suggesting a
complex regulation of neurogenic inflammatory response, as
summarized by Alawi and Keeble in an exemplary review [24].
These observations suggest that TRPV1 has a role in vascular
inflammation. Chronic physiological activation of TRPV1 ex-
pressing sensory neurons may contribute to the inflammatory
response and to painful effects such as hyperalgesia and allodynia
[24]. In particular, diabetic rats showed increased TRPV1
function (while TRPV1 expression decreased) in the dorsal root
ganglia [41], a feature which is similarly present in human diabetic
patients [42]. This represents a local feedback regulating TRPV1
activity: TRPV1 activation causes a desensitization of the TRPV1
itself (limiting hyperalgesia and allodynia), which is mediated by
decreased expression of TRPV1 in the tissues. This suggests that
TRPV1 desensitization has an effect on tissue perfusion. In
particular, diabetic or other kind of neuropathies result in a
decrease in TRPV1 expressing sensory neurons, mediating
vasodilation. As a result, patients with diabetes may have an
impaired regulation of blood flow leading to the dominance of
smooth muscle TRPV1 mediated vasoconstrictions over the
physiological sensory neuronal TRPV1 mediated vasodilations.
This altered vascular response may contribute to the progression
of the disease in the skin.
Figure 5. Functional effects of neonatal capsaicin desensitization on arteriolar TRPV1. Effects of neonatal capsaicin desensitization were
characterized on the functional properties of isolated, cannulated skeletal muscle arterioles. Endothelial responses were tested by the application of
acetylcholine (Panel A, values normalized to the maximal acetylcholine mediated dilations, symbols represent the mean 6 SEM, n= 4 for the control
and n=4 for the desensitized). Smooth muscle functions were assessed by norepinephrine (Panel B, symbols represent the mean 6 SEM of n= 4
determinations in both cases). The spontaneous myogenic tone (Panel C, symbols represent the mean 6 SEM of n= 4 determinations for all groups)
was tested by the contractile response developing in response to increasing intraluminal pressure (from 20 mmHg to 120 mmHg in 20 mmHg
increments). Finally, capsaicin mediated responses were also tested by the cumulative application of the drug. Capsaicin evoked a dose-dependent
constriction, supporting a physiological role for this receptor in vascular smooth muscle cells, which was not affected by the desensitization protocol
(Panel D, symbols represent the mean 6 SEM of n = 4 determinations for both groups).
doi:10.1371/journal.pone.0078184.g005
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The apparent difference between sensory neurons and vascular
smooth muscle cells in response to high capsaicin stimulation
(desensitization) described in this work may be explained by at
least two mechanisms. First, vascular smooth muscle cells are able
to proliferate, therefore the seriously damaged TRPV1 expressing
cells may be replaced. Alternatively, capsaicin damage is less
severe in vascular smooth muscle cells compared to sensory
neurons. To test this latter possibility, isolated arteries were treated
with capsaicin in vitro. Arteriolar TRPV1 was rapidly (within
minutes) desensitized to capsaicin and capsaicin treatment did not
affect TRPV1 independent functions, suggesting that capsaicin
mediated Ca2+ toxicity did not occur in these cells.
We propose that vascular smooth muscle cells can be activated
by the application of high doses of capsaicin, but the Ca2+ toxicity
is limited by fast desensitization, in accordance with previous
findings [12]. Vascular smooth muscle cells are therefore protected
from prolonged capsaicin treatments and maintain their viability.
These cells then are able to regenerate and regain capsaicin
responsiveness (and probably their physiological role) within a
short period of time. In contrast, sensory neurons seem to be
eliminated and not replaced upon neonatal capsaicin treatment.
Taken together, our data suggest that capsaicin desensitization is
an effective method to specifically regulate sensory functions, in
contrast with TRPV1 antagonists, which may affect vascular
TRPV1 mediated processes in addition to sensory functions.
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Figure 6. Functional effects of acute capsaicin desensitization on vascular TRPV1. The short-term effects of capsaicin were tested here.
Arterioles were isolated from control rats and were treated with capsaicin (1 mM, First treatment). Capsaicin was washed away after the 20 min long
treatment and the arterioles were incubated in the physiological buffer alone for 40 min (regeneration). Then capsaicin effects we re-tested (Second
treatment) to estimate the level of tachyphylaxis (n = 6 arteries were tested, symbols represent the mean6 SEM of time-matched arteriolar diameter).
Acute desensitization to capsaicin was apparent upon the first treatment (decrease and then increase in arteriolar diameter in the continuous
presence of capsaicin, maximal decrease was 7063% at 95 s after capsaicin application, Panel A). The magnitude of the response was decreased
upon the second capsaicin treatment on the same arterioles (tachyphylaxis, decreased response to repeated capsaicin stimuli, maximal decrease was
2769% at 125 s after capsaicin application, Panel A). This acute capsaicin desensitization (20 min treatment) did not affect norepinephrine mediated
constrictions (symbols represent the mean 6 SEM of n = 6 determinations, Panel B) or acetylcholine mediated dilations (symbols represent the mean
6 SEM, n = 6, Panel C).
doi:10.1371/journal.pone.0078184.g006
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